Linea Guida - Agenzia di Sanità Pubblica della Regione Lazio

More documents

Recommendations

Info

98 PROFILASSI DELLA TROMBOEMBOLIA VENOSA POST-CHIRURGICA Clarke-Pearson DL, Dodge RK, Synan I et al. 2003, Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression, Obstet Gynecol, 101: 157-63. Clarke-Pearson DL, Synan IS, Dodge R et al. 1993, A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery, Am J Obstet Gynecol, 168: 1146-54. Coe NP, Collins RE, Klein LA et al. 1978, Prevention of deep vein thrombosis in urological patients: a controlled, randomized trial of low-dose heparin and external pneumatic compression boots, Surgery, 83: 230-4. Cohen AT, Bailey CS, Alikhan R et al. 2001, Extended thromboprophylaxis with low-molecular-weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty: a meta-analysis, Thromb Haemost, 85: 940-1. Cohn SM, Moller BA, Feinstein AJ et al. 1999, Prospective trial of low-molecularweight heparin versus unfractionated heparin in moderately injured patients, Vasc Surg, 33: 219-23. Colachis SC, Clinchot DM 1993, The association between deep venous thrombosis and heterotopic ossification in patients with acute traumatic spinal cord injury, Paraplegia, 31: 507-12. Collins R, Baigent C, Sandercock P, Peto R 1994, Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists’ Collaboration, BMJ, 5; 309: 1215-7 (Review. No abstract available). Collins R, Scrimgeour A, Yusuf S et al. 1988, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery, N Engl J Med, 318: 1162-73. Colwell CW, Berkowitz SD, Davidson BL et al. 2003, Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement: a randomized, doubleblind study, J Thromb Haemost, 2003: 2119-30. Colwell CW, Collis DK, Paulson R et al. 1999, Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: evaluation during hospitalization and three months after discharge, J Bone Joint Surg Am, 81: 932-40. Colwell CW, Spiro TE, Trowbridge AA et al. 1994, Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep
BIBLIOGRAFIA venous thrombosis after elective hip replacement: a clinical trial comparing efficacy and safety, J Bone Joint Surg Am, 76: 3-14. Colwell CW, Spiro TE, Trowbridge AA et al. 1995, Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty, Clin Orthop, 321: 19-27. Comerota AJ, Chouhan V, Harada RN et al. 1997, The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis, Ann Surg; 226: 306-13; discussion 313-4. Comerota AJ, Katz ML, White JV 1992, Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail?, Am J Surg, 164: 265-8. Comp PC, Voegeli T, McCutchen JW et al. 1998, A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement, Orthopedics, 21: 1123-8. Constantini S, Kanner A, Friedman A et al. 2001, Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study, J Neurosurg, 94: 918-21. Cook D, Attia J, Weaver B et al. 2000, Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients, J Crit Care, 15: 127-32. Cook DJ, Crowther M, Meade M et al. 2003, Deep venous thrombosis in medicalsurgical ICU patients: prevalence, incidence and risk factors [abstract], Crit Care, 7 (suppl): S54 COPD. Am J Respir Crit Care Med 2000, 161: 1109-14. Cornwell EE, Chang D, Velmahos G et al. 2002, Compliance with sequential compression device prophylaxis in at-risk trauma patients: a prospective analysis, Am Surg, 68: 470-3. Crippa L, Ravasi F, D’Angelo SV et al. 1995, Diagnostic value of compression ultrasonography and fibrinogen-related parameters for the detection of postoperative deep vein thrombosis following elective hip replacement: a pilot study, Thromb Haemost, 74: 1235-9. Cruickshank MK, Levine MN, Hirsh J et al. 1991, A standard heparin nomogram for the manegement of heparin therapy, Arch Intern Med,151: 333-7. CSCM-Consortium for Spinal Cord Medicine 1997, Prevention of thromboembolism in spinal cord injury, J Spinal Cord Med, 20: 259-83. Dabrowiecki S, Rosc D, Jurkowski P 1997, The influence of laparoscopic cholecystectomy on perioperative blood clotting and fibrinolysis, Blood Coagul Fibrinolysis, 8: 1-5. Dahl OE, Aspelin T, Arnesen H et al. 1995, Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery, Thromb Res, 80: 299-306. 99
Page 1 and 2:
LAZIOSANITÀ - AGENZIA DI SANITÀ P
Page 3 and 4:
Indice p. 6 Il Gruppo di Lavoro 9 1
Page 5 and 6:
p. 69 8. Traumi Raccomandazioni 72
Page 7 and 8:
Prof. Raffaele Landolfi Professore
Page 9 and 10:
10 PROFILASSI DELLA TROMBOEMBOLIA V
Page 11 and 12:
Page 13 and 14:
Page 16 and 17:
2. Metodi di sviluppo della Linea G
Page 18 and 19:
- exp heparin, low-molecular-weight
Page 20 and 21:
METODI DI SVILUPPO DELLA LINEA GUID
Page 22 and 23:
- pubblicazioni scientifiche; - pre
Page 24 and 25:
3. I fattori di rischio per la trom
Page 26 and 27:
I FATTORI DI RISCHIO PER LA TROMBOE
Page 28 and 29:
4. Metodi per la profilassi Di segu
Page 30 and 31:
METODI PER LA PROFILASSI to risulta
Page 32 and 33:
METODI PER LA PROFILASSI Raccomanda
Page 34:
Eparine a basso peso molecolare. Le
Page 37 and 38:
Page 39 and 40:
Nome e anno Mismetti 2001 Koch 2001
Page 41 and 42:
Page 43 and 44:
Page 45 and 46: 46 PROFILASSI DELLA TROMBOEMBOLIA V
Page 48 and 49: 6. Chirurgia vascolare 6.1. Chirurg
Page 50 and 51: 7. Chirurgia ortopedica e neurochir
Page 52 and 53: considerati nella LG dell’ACCP, s
Page 54 and 55: 7.1.3. Profilassi farmacologica CHI
Page 56 and 57: CHIRURGIA ORTOPEDICA E NEUROCHIRURG
Page 62 and 63: 7.6. Durata della profilassi CHIRUR
Page 66 and 67: dell’ACCP, settima revisione (Gee
Page 68 and 69: 8. Traumi I pazienti politraumatizz
Page 70 and 71: ati di contenzione (Greenfield 1997
Page 72 and 73: TRAUMI degli arti inferiori ed il r
Page 74 and 75: 9. Farmaci antitrombotici ed aneste
Page 76 and 77: FARMACI ANTITROMBOTICI ED ANESTESIA
Page 78 and 79: 10. Terapia intensiva I pazienti ch
Page 80 and 81: 11. Pazienti con malattia oncologic
Page 82: Sintesi per i pazienti I pazienti c
Page 86 and 87: A. Indagini diagnostiche di screeni
Page 88 and 89: B. Elenco delle principali Linee Gu
Page 98 and 99: 100 PROFILASSI DELLA TROMBOEMBOLIA
show all

Linea Guida - Agenzia di Sanità Pubblica della Regione Lazio

Create successful ePaper yourself

Delete template?

Save as template?